Drug-Free Workplace Act — Federal Contractor & Grantee Requirements

The Drug-Free Workplace Act of 1988 (41 U.S.C. §§ 8101–8106) requires all organizations that receive federal contracts over $150,000 or any federal grant to certify that they will maintain a drug-free workplace. This doesn't mean mandatory drug testing (that's a separate requirement for certain federal employees and safety-sensitive positions) — it means the organization must publish a drug-free workplace policy, establish a drug awareness program, notify employees of the policy, require employees to report drug convictions, and take appropriate personnel action against employees convicted of workplace drug violations. Organizations that fail to comply or make false certifications can be suspended or debarred from receiving future federal contracts and grants — a potentially devastating penalty for organizations that depend on federal funding.

Current Law (2026)

Parameter	Value
Governing law	41 U.S.C. §§ 8101–8106 (Drug-Free Workplace Act, 1988)
Contract threshold	$150,000 or more (originally $25,000; increased by FAR amendments)
Grant threshold	Any federal grant (no dollar minimum)
Applies to	Federal contractors, federal grant recipients (organizations, not individuals receiving grants under $25,000)
Required actions	Publish policy statement; establish awareness program; notify employees; report convictions; impose sanctions
Employee obligation	Must notify employer within 5 days of any criminal drug conviction for workplace violation
Employer response	Must notify contracting/granting agency within 10 days of employee conviction; must take action within 30 days
Penalties for non-compliance	Suspension, debarment, or contract/grant termination
Relationship to drug testing	Act does NOT require drug testing — it requires a drug-free workplace policy and program

Legal Authority

41 U.S.C. § 8102 — Drug-free workplace requirements for federal contractors (contractors with contracts over $150,000 must certify they will provide a drug-free workplace; specifies the required elements of the drug-free workplace program)
41 U.S.C. § 8103 — Drug-free workplace requirements for federal grant recipients (grantees must make the same certification; applies to all grants regardless of dollar amount, though individual grants under $25,000 are exempt)
41 U.S.C. § 8104 — Employee sanctions and remedies (contractors/grantees must take appropriate personnel action against convicted employees — up to and including termination — or require participation in a drug abuse assistance or rehabilitation program)
41 U.S.C. § 8105 — Waiver (agency head may waive requirements with respect to a particular contract or grant if the waiver is in the national interest; waivers are rare and must be reported to Congress)
41 U.S.C. § 8106 — Regulations (government-wide regulations implementing the Act)

How It Works

Before receiving a covered federal contract or grant, the organization must certify it will maintain a drug-free workplace — a false certification creates criminal fraud exposure on top of administrative sanctions. Once certified, six program elements are required: (1) publish a written statement prohibiting unlawful manufacture, distribution, dispensation, possession, or use of controlled substances in the workplace and specifying consequences for violations; (2) establish a drug-free awareness program informing employees about drug abuse dangers, the policy, available employee assistance programs, and penalties; (3) give every employee engaged in contract/grant work a copy of the statement; (4) require each employee to agree to abide by the policy and to notify the employer within 5 calendar days of any criminal drug conviction for a workplace violation; (5) notify the contracting or granting agency within 10 calendar days of receiving notice of an employee conviction; and (6) take appropriate personnel action against the convicted employee within 30 days — either discipline up to termination or require satisfactory participation in a drug rehabilitation program.

Critically, the Act does not require drug testing — it requires a policy, a program, and action on convictions. Drug testing authority comes from separate sources: Executive Order 12564 for federal civil service employees, DOT regulations for safety-sensitive transportation workers, NRC regulations for nuclear workers. Non-compliance exposes the organization to suspension (temporary exclusion from federal contracts and grants), debarment (typically up to 3 years), or contract termination — consequences that can be existential for organizations heavily dependent on federal funding such as universities, defense contractors, healthcare systems, and nonprofits. The Act's definition of "controlled substance" references the Controlled Substances Act — which still classifies marijuana as Schedule I regardless of state law. An employee in a legal-marijuana state convicted of a workplace-related marijuana offense still triggers the notification and sanction requirements.

How It Affects You

If you work for a federal contractor or federal grantee: Your employer's drug-free workplace policy applies to you. The key things you need to know: (1) The policy must be written and distributed — your employer is required to give you a copy and ensure you know what substances are prohibited and what the consequences of violations are. If you've never received one, ask HR. (2) Convictions trigger a notification obligation: if you're convicted of any criminal drug offense for conduct that occurred at the workplace, you must notify your employer within 5 calendar days. This is not optional — failure to notify can be grounds for termination independent of the conviction itself. (3) The policy covers workplace conduct, not all drug use — the Act targets drug violations "occurring in the workplace," not off-duty substance use generally. However, many employer policies go beyond the Act's requirements and include off-duty drug testing provisions; your employer's actual policy (not just the Act) governs your situation.

Marijuana and federal employment: Even if you're in a state where recreational marijuana is legal, your employer's drug-free workplace certification covers marijuana under federal law. The Controlled Substances Act still classifies marijuana as Schedule I, so a workplace conviction for marijuana possession would trigger the Act's requirements regardless of your state's law. Drug testing programs (if your employer has one) often include marijuana even in legal states; ask about your employer's specific testing policy and consequences before using marijuana legally in your state if you work for a federal contractor or grantee.

Employee assistance programs (EAPs): The Act requires your employer to maintain a drug awareness program that includes information about available counseling and rehabilitation programs. Most medium and large employers satisfy this by maintaining an EAP — typically a third-party service providing free, confidential counseling sessions for substance abuse and other personal issues. Ask HR about your EAP if you're dealing with substance use issues. Using your EAP proactively (before a workplace incident) is generally confidential and protects your employment; a workplace drug conviction after the fact is not.

If you're an employer with federal contracts over $150,000 or any federal grants: Your drug-free workplace compliance requirements attach at award — the certification in your contract (under FAR clause 52.223-6) or grant agreement is a legal representation, and false certification can constitute fraud. The minimum required program elements that you must actually implement:

Written policy statement: Must be distributed to every employee engaged on the covered contract/grant, stating specifically (a) what's prohibited (unlawful manufacture, distribution, dispensing, possession, or use of controlled substances at the workplace), (b) what your workplace is (name the location), and (c) what actions will be taken against violators.
Drug awareness program: Must educate employees about drug dangers, your policy, available EAP or counseling resources, and the penalties for violations. Annual training or orientation is the common approach — document attendance.
Employee acknowledgment: Each employee working on the contract/grant must agree to abide by the terms of the policy and must be told of their obligation to report convictions.
Conviction reporting system: You must have a process to receive employee notifications within 5 days of a workplace drug conviction, and then notify the contracting/granting agency within 10 calendar days of receiving that notice.
Personnel action: Within 30 calendar days of receiving notice of an employee's conviction, you must take appropriate action — disciplinary action up to termination, or require participation in a drug abuse assistance or rehabilitation program approved for employee assistance purposes.

Documentation is your defense: Keep records of policy distributions, awareness program attendees, any employee acknowledgments, and all notifications received and sent. In a debarment proceeding, documented compliance is the difference between a good-faith violation (typically resulting in a compliance agreement) and a willful violation (potentially resulting in debarment).

Marijuana policy decisions in a legal-state environment: You face a real tension. Federal law still classifies marijuana as Schedule I, so your drug-free workplace certification covers marijuana. But in states with legal recreational marijuana, overly aggressive enforcement may cause you to lose employees. Practical approaches employers are adopting: (1) distinguish between safety-sensitive and non-safety-sensitive positions in your testing program, applying stricter policies to safety-sensitive roles; (2) focus testing on reasonable cause (observed impairment) rather than pre-employment or random testing for non-safety-sensitive positions; (3) ensure your policy clearly distinguishes between possession/use at the workplace (which you must prohibit) and off-duty use (which you may address but aren't required to prohibit under the Act). Get legal counsel in your state on how state employment law interacts with your federal drug-free workplace obligations.

If you're a university, research institution, or nonprofit receiving federal grants: The no-dollar-threshold rule for grants means even a $5,000 community grant triggers the certification requirement. For universities — which receive hundreds of federal grants simultaneously — the institutional approach is to maintain a single drug-free workplace policy and awareness program that covers the institution as a whole, with the federal grant administrator certifying on behalf of the institution. Decentralized institutions with many semi-autonomous units should ensure that each unit understands the policy exists and that conviction notification obligations are met — it's surprisingly common for a department to receive a conviction notification and not route it to compliance staff within the required 10-day window. The federal granting agency for each award is the entity that must receive notification of employee convictions — keep a log of which grants are active and which agency officer to notify for each.

For research institutions: employees working on federally sponsored research projects are the employees "engaged in the performance of" the grant. Track which employees are on which grants; your HR and sponsored programs offices need to coordinate so that a conviction notification from a researcher triggers the right grant notifications.

State Variations

The Drug-Free Workplace Act is federal, but intersects with state drug laws:

State marijuana legalization does not override the Act's requirements — marijuana remains a controlled substance under federal law
Some states have their own drug-free workplace acts with additional requirements
State laws may limit employer drug testing practices (even if testing goes beyond the Act's requirements)
State workers' compensation laws may provide incentives or premium discounts for drug-free workplace programs
State wrongful termination laws may affect how employers implement sanctions for drug-related violations

Implementing Regulations

2 CFR Part 182 — Government-Wide Requirements for Drug-Free Workplace (Financial Assistance) (40 sections — OMB's governmentwide guidance implementing the Drug-Free Workplace Act for recipients of federal financial assistance; all federal agencies that award grants, cooperative agreements, or other financial assistance must adopt these requirements in their own assistance regulations, and recipients must comply as a condition of their award):
- Organization recipients (§§ 182.200–182.230): a recipient that is an organization (nonprofit, university, company) must implement a genuine, ongoing drug-free awareness program — not just a one-time policy publication; the required elements include: (1) a written drug-free workplace statement telling employees that unlawful manufacture, distribution, dispensing, possession, or use of a controlled substance is prohibited in the covered workplace; (2) distribution of that statement to every employee who will work on any federal award; (3) an ongoing drug-free awareness program explaining workplace drug dangers, the employer's policy, available employee assistance resources, and the consequences of violations; (4) identification of the specific workplaces where federal award work will be performed
- Employee conviction notification (§ 182.225): when an employee who works on a federal award is convicted of a drug violation occurring in the covered workplace, the recipient must notify the awarding federal agency within 10 days of learning of the conviction; within 30 days of learning of the conviction, the recipient must take appropriate personnel action against the convicted employee (up to and including termination) or require the employee to satisfactorily participate in a drug abuse assistance or rehabilitation program
- Individual recipients (§ 182.300): individual recipients (a person, not an organization, receiving a personal research fellowship, scholarship, or other individual award) have a simpler requirement — they must certify that they will remain drug-free during performance of the award; no workplace policy or awareness program is required for individual grants
- Agency implementation (§§ 182.15–182.25): each federal agency that awards financial assistance must create its own implementing regulation that adopts 2 CFR Part 182 by reference or incorporates its requirements; the agency may grant exceptions on an award-by-award basis; agency heads may exempt specific awards from the drug-free requirements if they determine the exemption is in the national interest
- Debarment consequences (§ 182.125): violations of the drug-free workplace requirements can lead to suspension or debarment from federal financial assistance under 2 CFR Part 180; otherwise, the requirement does not affect a recipient's federal contract relationships, which are governed separately by the FAR
2 CFR Part 1401 — Department of the Interior Drug-Free Workplace Requirements for Financial Assistance (34 sections — DOI's implementing regulation for the Drug-Free Workplace Act's grant recipient requirements; all 34 sections are subparts of the OMB baseline at 2 CFR Part 182, with DOI-specific procedural details that differ meaningfully from the government-wide template):
- Award timing (§ 1401.320): for awards lasting 30+ days, recipients must publish the drug-free workplace statement and establish the drug-free awareness program within 30 days of receiving the award; for awards shorter than 30 days, the program must be in place before the work is expected to finish; recipients who need more than 30 days may request an extension from the DOI awarding official
- No central notification point (§§ 1401.335, 1401.401): unlike some agencies that designate a central office to receive employee drug conviction notifications, DOI does not — when an employee is convicted of a workplace drug crime, the recipient (or the convicted individual, in the case of individual awards) must separately notify each relevant grant officer or designee for each affected award
- Violation determinations (§§ 1401.600–1401.605): the Director of the Office of Acquisition and Property Management (Director, PAM) is the designated official who makes written determinations that a recipient has violated the drug-free requirements — either for violating the program requirements or because the pattern of employee convictions shows the recipient failed to make a good-faith effort to maintain a drug-free workplace
- Consequences (§ 1401.610): upon a violation finding, the government may stop award payments, suspend or terminate the award, and/or suspend or debar the recipient — debarment cannot exceed 5 years
- Secretary-only exceptions (§ 1401.615): the Secretary of the Interior personally (not a delegate) may make written exceptions for specific awards — allowing continued payments, rescinding a suspension or termination, or declining to enforce debarment — if in the public interest; this non-delegable authority at the Cabinet level reflects the seriousness with which exceptions are treated
- International conflict exemption (§ 1401.115): DOI may exempt an award from the drug-free requirements if compliance would conflict with U.S. international commitments or with another country's laws — relevant for DOI-funded field research or cooperative programs in countries with different legal frameworks for controlled substances
2 CFR 1329.30–.400 — SBA drug-free workplace requirements (Small Business Administration implementation for recipients of SBA grants)
48 CFR 23.5 — FAR Subpart 23.5 — Drug-free workplace requirements for federal contractors (contract clause, contractor obligations, suspension/debarment for violations)

Pending Legislation

No standalone Drug-Free Workplace Act reform bills have been introduced in the 119th Congress. Related drug policy and federal workplace provisions may appear in broader labor and government operations legislation — see Federal Employment Law and Controlled Substances Act.

Recent Developments

The expansion of state marijuana legalization has created increasing tension with the Drug-Free Workplace Act's federal framework. Some federal agencies have softened their approach to past marijuana use in hiring (notably the FBI and security clearance process), but the Act's requirements for workplace drug-free certification remain unchanged. The opioid crisis has raised questions about the intersection of prescription drug use and workplace drug policies. Proposed federal marijuana rescheduling or legalization would fundamentally change the Act's practical impact by removing marijuana from the controlled substances that trigger its requirements.